Source: Annual Congress 2006 - COPD – therapy/exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Coskun, E. Ege, E. Uzaslan, D. Ediger, M. Karadag, O. Gozu (Bursa, Turkey). The relationship between thyroid hormones, somatomedin-C (IGF-1), anabolic hormones and the severity of disease in chronic obstructive lung disease (COPD). Eur Respir J 2006; 28: Suppl. 50, 290

Member's Comments

No comment yet.

Related content which might interest you: Endocrinological disturbances in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 76S-80S Year: 2003 Association between serum leptin, nutritional status and severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008 Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 The effects of serum leptin on bone metabolism in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 564s Year: 2002 Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015 Role of oxidative-antioxidative imbalance and thyroid hormones in stable chronic obstructive pulmonary disease Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 PP310 – Association of testosterone with lung function in patients with chronic obstructive lung disease Source: ERS Lung Science Conference 2021 Year: 2021 Anabolic steroids in acute and chronic disease Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=163 Year: 2003 Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001 Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Leptin receptor polymorphisms and lung function decline in COPD Source: Eur Respir J 2009; 34: 103-110 Year: 2009 Leptin, visfatin, insulin resistance, body composition change in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Systemic effects of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224 Year: 2006 Low testosterone in chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013